195 related articles for article (PubMed ID: 24089532)
21. Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines.
Holko M; Williams BR
J Interferon Cytokine Res; 2006 Aug; 26(8):534-47. PubMed ID: 16881864
[TBL] [Abstract][Full Text] [Related]
22. The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma.
Zhang ZY; Zhang SL; Chen HL; Mao YQ; Li ZM; Kong CY; Han B; Zhang J; Chen YH; Xue W; Zhai W; Wang LS
Cell Prolif; 2020 Jul; 53(7):e12853. PubMed ID: 32537867
[TBL] [Abstract][Full Text] [Related]
23. Progress of SLFN family proteins in tumor and virus infection.
Chen SM; Ma L; Cen S
Yi Chuan; 2020 May; 42(5):444-451. PubMed ID: 32431296
[TBL] [Abstract][Full Text] [Related]
24. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.
Fischietti M; Eckerdt F; Blyth GT; Arslan AD; Mati WM; Oku CV; Perez RE; Lee-Chang C; Kosciuczuk EM; Saleiro D; Beauchamp EM; Lesniak MS; Verzella D; Sun L; Fish EN; Yang GY; Qiang W; Platanias LC
Oncogene; 2021 May; 40(18):3273-3286. PubMed ID: 33846574
[TBL] [Abstract][Full Text] [Related]
25. VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR.
Liu C; Liu L; Wang K; Li XF; Ge LY; Ma RZ; Fan YD; Li LC; Liu ZF; Qiu M; Hao YC; Shi ZF; Xia CY; Strååt K; Huang Y; Ma LL; Xu D
Oncogene; 2020 May; 39(21):4286-4298. PubMed ID: 32291411
[TBL] [Abstract][Full Text] [Related]
26. AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction.
Chai D; Shan H; Wang G; Li H; Fang L; Song J; Zhang Q; Bai J; Zheng J
Exp Cell Res; 2018 Sep; 370(2):561-570. PubMed ID: 30031129
[TBL] [Abstract][Full Text] [Related]
27. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
[TBL] [Abstract][Full Text] [Related]
28. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif.
Geserick P; Kaiser F; Klemm U; Kaufmann SH; Zerrahn J
Int Immunol; 2004 Oct; 16(10):1535-48. PubMed ID: 15351786
[TBL] [Abstract][Full Text] [Related]
29. Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness.
Momoi Y; Nishida J; Miyakuni K; Kuroda M; Kubota SI; Miyazono K; Ehata S
Cancer Sci; 2021 Aug; 112(8):3136-3149. PubMed ID: 34091990
[TBL] [Abstract][Full Text] [Related]
30. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
31. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
[TBL] [Abstract][Full Text] [Related]
32. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
33. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.
Lichtenfels R; Dressler SP; Zobawa M; Recktenwald CV; Ackermann A; Atkins D; Kersten M; Hesse A; Puttkammer M; Lottspeich F; Seliger B
Mol Cell Proteomics; 2009 Dec; 8(12):2827-42. PubMed ID: 19752005
[TBL] [Abstract][Full Text] [Related]
34. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
35. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
36. Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1.
Brady G; Boggan L; Bowie A; O'Neill LA
J Biol Chem; 2005 Sep; 280(35):30723-34. PubMed ID: 15946944
[TBL] [Abstract][Full Text] [Related]
37. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
[TBL] [Abstract][Full Text] [Related]
40. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
